Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Published:2016-02-02 Issue:1 Volume:85 Page:137-149
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Chan Jean L.¹,Koda Joy¹,Heilig Joseph S.²,Cochran Elaine K.³,Gorden Phillip³,Oral Elif A.⁴,Brown Rebecca J.³

Affiliation:

1. Bristol-Myers Squibb; Princeton NJ USA

2. AstraZeneca; San Diego CA USA

3. National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda MD USA

4. Division of Metabolism, Endocrinology & Diabetes (MEND); University of Michigan; Ann Arbor MI USA

Funder

AstraZeneca

Bristol-Myers Squibb

Amylin Pharmaceuticals

National Institutes of Health

Nutrition Obesity Research Center (NORC)

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference25 articles.

1. Positional cloning of the mouse obese gene and its human homologue;Zhang;Nature,1994

2. 20 years of leptin: leptin at 20: an overview;Friedman;Journal of Endocrinology,2014

3. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial;Heymsfield;JAMA,1999

4. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy;Ravussin;Obesity (Silver Spring),2009

5. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies;Roth;Proceedings of the National Academy of Sciences of the United States of America,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Lipodystrophy: Insights from Laminopathies and Beyond;International Journal of Molecular Sciences;2024-07-23

2. Leptin replacement therapy in the management of lipodystrophy syndromes;Annales d'Endocrinologie;2024-06

3. Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases;Alimentary Pharmacology & Therapeutics;2024-05-30

4. Effects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease;The Journal of Clinical Endocrinology & Metabolism;2024-05-17

5. Relative Energy Deficiency in Sport (REDs): Endocrine Manifestations, Pathophysiology and Treatments;Endocrine Reviews;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3